Nektar Therapeutics | NKTR - Current Assets

Stock Price
67.03
Daily Change
11.03 19.70%
Monthly
72.89%
Yearly
511.31%
Q1 Forecast
1.21

Nektar Therapeutics reported $281.36M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Agios Pharmaceuticals USD 1.03B 13.64M Sep/2025
ALKERMES USD 1.74B 106.38M Sep/2025
Alterity Therapeutics Limited AUD 27.05M 6.16M Jun/2023
Amgen USD 29.06B 1.17B Dec/2025
Baxter International USD 6.93B 184M Sep/2025
BioCryst Pharmaceuticals USD 355.68M 42.78M Sep/2025
Biogen USD 8.97B 37.5M Dec/2025
Bristol-Myers Squibb USD 35.63B 2.41B Sep/2025
Cara Therapeutics USD 43.13M 4.18M Jun/2025
Cipla INR 249.18B 16.3B Sep/2025
Dr.Reddys Laboratories INR 297.55B 18.03B Dec/2025
Eisai JPY 840.88B 50.18B Dec/2025
Eli Lilly USD 62.07B 12.22B Sep/2025
Esperion Therapeutics USD 360.46M 17.87M Sep/2025
Exelixis USD 1.44B 41.03M Dec/2025
Gilead Sciences USD 19.89B 1.05B Dec/2025
GlaxoSmithKline GBP 17.51B 332M Dec/2025
Grifols EUR 6.28B 92.48M Sep/2025
Halozyme Therapeutics USD 1.33B 206.08M Sep/2025
Incyte USD 5.02B 746.01M Dec/2025
Ionis Pharmaceuticals USD 2.52B 58.16M Sep/2025
Ironwood Pharmaceuticals USD 273.84M 82.09M Sep/2025
Karyopharm Therapeutics USD 89.75M 8.12M Sep/2025
MacroGenics USD 232.09M 27.15M Sep/2025
Merck USD 47.56B 10.49B Sep/2025
Nektar Therapeutics USD 281.36M 94.79M Sep/2025
Neurocrine Biosciences USD 2.52B 364.3M Dec/2025
Novartis USD 28.2B 2.26B Sep/2025
Pfizer USD 46.92B 3.22B Sep/2025
Roche Holding CHF 38.73B 3.03B Dec/2025
Sarepta Therapeutics USD 2.72B 65.32M Sep/2025
Takeda JPY 3.12T 195.82B Dec/2025
Teva Pharmaceutical Industries USD 13.95B 1.21B Dec/2025
Xencor USD 518.44M 5.29M Sep/2025